GeneProof Direct Detection of SARS-CoV-2

For our customers, we have prepared the method of direct diagnostics of a novel coronavirus from respiratory samples without RNA extraction.

Direct detection of SARS-CoV-2 is based on lysis of real clinical material and enables the rapid detection by simplifying and shortening of the laboratory procedure.

The method applies for both our new products GeneProof SARS-CoV-2 PCR Kit, as well as the new GeneProof SARS-CoV-2 Screening PCR Kit.
The both products also contain unique internal control (IC) consisted of enveloped nucleoprotein particle which completely imitates natural SARS-CoV-2 virus particle.

These kits are the only SARS-CoV-2 diagnostics which really control all detection steps individually in each examined clinical specimen: lysis of virus envelope + lysis of virus nucleoprotein particle and viral RNA release + reverse transcription step + PCR amplification efficiency and inhibition.

Moreover, both kits comprise of extremely robust components, which suppress the inhibitors´ influence usually present in this kind of clinical samples.Therefore, these two diagnostic kits are the only diagnostics which allow fully controlled direct SARS-CoV-2 RNA detection in clinical specimens.

The GeneProof company guarantees the functionality of direct detection of the transport medium PBS (Phosphate Buffered Saline), ESwab, UTM.

GeneProof declaration, a protocol for direct detection and verification of using a transport medium are available on request.

Our support department is prepared to help you with validation.